CLT Vigilance Consulting (CLT) supports sponsors and CROs in safeguarding patient safety and ensuring the medical integrity of clinical trials/clinical investigations and marketed products.
Combining clinical experience, regulatory know-how, and operational insight, Cornelia Lif-Tiberg, MD and CLT Founder, provides independent expertise in Medical Monitoring, Pharmacovigilance, strategic Medical Advisory, and independent Safety Committees.
Our focus is simple: protect patients, defend data quality, and enable confident and ethical decisions.
The greatest impact is achieved when clinical thinking stays closely connected to how trials are actually run.
At CLT Vigilance Consulting, medical insight guides the design, but real value comes from being present — actively reviewing data, maintaining continuous dialogue with study teams and sponsors, and providing hands-on support to sites when questions or challenges arise.
Every project, protocol, and product has one shared priority — patient safety.
CLT Vigilance Consulting supports sponsors, CROs, and biotech innovators with independent medical expertise throughout the product life cycle, from first-in-human studies to late-phase trials and post-marketing surveillance.
Combining clinical experience, regulatory understanding, and operational insight, Cornelia Lif-Tiberg, MD, ensures smarter safety decisions — grounded in science, ethics, and compliance.
Clinical safety is most effective when risks are identified early, escalated clearly, and documented to high regulatory and quality standards.
At CLT Vigilance Consulting, the approach is proactive and continuous — staying alert to early signals through active medical review and close site engagement, anticipating potential pitfalls, and acting on risks before they evolve.
Every clinical program deserves experienced medical oversight that protects participants, strengthens data, and satisfies regulators.
At CLT Vigilance Consulting, this is enabled through the expertise of Cornelia Lif-Tiberg, MD, who combines hands-on clinical decision-making from Anesthesia and Intensive Care with years of operational responsibility in contract research and drug development.
This allows safety events to be interpreted in full context — medically, operationally, and regulatorily.